RGNX REGENXBIO Inc.
High-Growth Software
F 17.5 / 100 pillar composite

AlphaQuality composite grade, weighted for high-growth software businesses.

⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.

Grade overrides the 17.5 pillar composite — hard gates always win.

Profitability

Weight: 15%
F 0
  • 5yr Avg ROIC -30.9%
  • Operating Margin Trend -30.40 pp/yr

Capital Efficiency

Weight: 15%
F 3
  • 5yr Avg ROE -162.9%
  • 5yr Share-Count CAGR 4.1%

Growth Quality

Weight: 35%
F 15
  • 5yr Revenue CAGR -22.4%
  • 5yr EPS CAGR 0.0%
  • Revenue-Growth Years (5) 2/5

Cash Generation

Weight: 20%
C- 45
  • 5yr FCF Margin -144.1%
  • 5yr FCF/NI Conversion 1.05x

Balance Sheet

Weight: 10%
F 0
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) -3.31x
  • Altman Z-Score -5.69

Stability

Weight: 5%
C+ 58
  • EPS Volatility (σ/μ) 0.00
  • Piotroski F-Score 1
  • Negative-Revenue Years (5) 3/5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Accumulating

2 of 2 gurus held; 2 added.

Holders
2
Avg Δ position
+318.5%
New buys
0
Full exits
0
As of Q1 2026